News

Lilly to launch Mounjaro pen in India to compete with Novo's weight-loss drug Wegovy
Eli Lilly said on Thursday that India's drug regulator had approved the launch of pre-filled injector pens of its blockbuster ...
Wegovy: The price, perks, and pitfalls of India’s new weight-loss craze
Wegovy, the ₹26K/month weight-loss jab, hits India with bold promises—from fat loss to heart health. But is this pharma fix a ...
Explained: Everything you need to know ahead of Wegovy's NZ arrival
The count-down's on for New Zealand chemist sales of weight-loss drug Wegovy. A pharmacist has told our newsroom the ...
New data show most patients now stay on Wegovy, Zepbound after a year
Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year ...
Wegovy vs Mounjaro: Eli Lilly to launch full-dose pen device in India as obesity drug race heats up
With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, ...
The Financial Express1d
Wegovy now available in India: Doctors explain cost, who should take it and key side effects
Wegovy, a weekly weight-loss injection by Novo Nordisk, has launched in India. Priced from Rs 17,000/month, it helps users lose up to 20 per cent body weight. But is it safe? Experts answer.
Strict criteria Brits need to fit in order to be eligible for Wegovy from NHS
NICE says that in some exceptional circumstances the BMI requirements can drop down to 30, and people from some ethnic ...
Mounjaro, Ozempic, Wegovy side effects study launched after hundreds get painful tummy condition
The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a new study into GLP-1 medicines after worrying ...